Axogen, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Axogen, Inc. (AXGN) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$557.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-24
- Axogen, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$557.00K, a 276.83% decline from fiscal 2024.
- Axogen, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $315.00K, a 88.87% decline from fiscal 2023.
- Axogen, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $2.83M, a 44.03% decline from fiscal 2022.
- Axogen, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $5.06M, a 24.89% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$557.00K 10-K · filed 2026-02-24 | |
| 2024-12-31 | $315.00K 10-K · filed 2026-02-24 | |
| 2023-12-31 | $2.83M 10-K · filed 2025-02-26 | |
| 2022-12-31 | $5.06M 10-K · filed 2024-03-05 | |
| 2021-12-31 | $6.73M 10-K · filed 2023-03-14 | |
| 2020-12-31 | $6.58M 10-K · filed 2022-02-25 | |
| 2019-12-31 | $6.06M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $5.52M 10-K · filed 2021-03-01 | |
| 2017-12-31 | -$10.75M 10-K · filed 2020-02-24 | $10.80M 10-K · filed 2018-02-28 |
| 2016-12-31 | $5.10M 10-K · filed 2019-02-26 | $5.10M 10-K · filed 2017-03-01 |
| 2015-12-31 | $4.50M 10-K · filed 2018-02-28 | $4.45M 10-K · filed 2016-02-29 |
| 2014-12-31 | $6.20M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $4.96M 10-K · filed 2015-03-05 | |
| 2012-12-31 | $3.02M 10-K · filed 2014-03-06 | |
| 2011-12-31 | $3.57M 10-K/A · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |